The University of Chicago Header Logo

Connection

Sarosh Rana to Hypertension, Pregnancy-Induced

This is a "connection" page, showing publications Sarosh Rana has written about Hypertension, Pregnancy-Induced.
Connection Strength

12.510
  1. Effect of postpartum oral furosemide use on postpartum readmissions and blood pressure trends. Pregnancy Hypertens. 2025 Mar; 39:101199.
    View in: PubMed
    Score: 0.798
  2. Systematic treatment and management of postpartum hypertension using remote patient monitoring. Pregnancy Hypertens. 2025 Mar; 39:101180.
    View in: PubMed
    Score: 0.792
  3. Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2025 Apr; 232(4):385.e1-385.e21.
    View in: PubMed
    Score: 0.769
  4. Patient perceptions of remote patient monitoring program for hypertensive disorders of pregnancy. Arch Gynecol Obstet. 2024 09; 310(3):1563-1576.
    View in: PubMed
    Score: 0.767
  5. Discharge medication delivery location and postpartum blood pressure control in patients with hypertensive disorders of pregnancy. Pregnancy Hypertens. 2024 Jun; 36:101125.
    View in: PubMed
    Score: 0.757
  6. Racial Differences in Readmissions in Hypertensive Disorders of Pregnancy. Reprod Sci. 2022 07; 29(7):2071-2078.
    View in: PubMed
    Score: 0.655
  7. Women's perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia. Pregnancy Hypertens. 2022 Jun; 28:109-113.
    View in: PubMed
    Score: 0.654
  8. Racial Disparities in Diagnosis, Management, and Outcomes in Preeclampsia. Curr Hypertens Rep. 2022 04; 24(4):87-93.
    View in: PubMed
    Score: 0.653
  9. Elimination of racial disparities in postpartum hypertension follow-up after incorporation of telehealth into a quality bundle. Am J Obstet Gynecol MFM. 2022 05; 4(3):100580.
    View in: PubMed
    Score: 0.648
  10. Postpartum Outcomes With Systematic Treatment and Management of Postpartum Hypertension. Obstet Gynecol. 2021 11 01; 138(5):777-787.
    View in: PubMed
    Score: 0.637
  11. Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension. Hypertension. 2021 09; 78(4):927-935.
    View in: PubMed
    Score: 0.628
  12. Real-World Use of Biomarkers in Management of Hypertension During Pregnancy: Adjunct to Clinical Care. Hypertension. 2021 02; 77(2):472-474.
    View in: PubMed
    Score: 0.603
  13. Angiogenic factor abnormalities and risk of peripartum complications and prematurity among urban predominantly obese parturients with chronic hypertension. Pregnancy Hypertens. 2020 Apr; 20:124-130.
    View in: PubMed
    Score: 0.571
  14. Effect of blood pressure control in early pregnancy and clinical outcomes in African American women with chronic hypertension. Pregnancy Hypertens. 2020 Apr; 20:102-107.
    View in: PubMed
    Score: 0.570
  15. Severe antepartum hypertension and associated peripartum morbidity among pregnant women in an urban tertiary care medical center. Pregnancy Hypertens. 2020 Jan; 19:31-36.
    View in: PubMed
    Score: 0.560
  16. Understanding and comparing practices of managing patients with hypertensive disorders of pregnancy in urban China and the United States. Pregnancy Hypertens. 2019 Jul; 17:253-260.
    View in: PubMed
    Score: 0.544
  17. Activin A and Late Postpartum Cardiac Dysfunction Among Women With Hypertensive Disorders of Pregnancy. Hypertension. 2018 07; 72(1):188-193.
    View in: PubMed
    Score: 0.502
  18. Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy. Hypertension. 2016 06; 67(6):1273-80.
    View in: PubMed
    Score: 0.435
  19. Report from a text-based blood pressure monitoring prospective cohort trial among postpartum women with hypertensive disorders of pregnancy. BMC Pregnancy Childbirth. 2024 May 03; 24(1):340.
    View in: PubMed
    Score: 0.189
  20. Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy. NEJM Evid. 2022 Dec; 1(12):EVIDoa2200161.
    View in: PubMed
    Score: 0.171
  21. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022 02; 79(2):e21-e41.
    View in: PubMed
    Score: 0.161
  22. Hypertensive Diseases of Pregnancy Increase Risk of Readmission With Heart Failure: A National Readmissions Database Study. Mayo Clin Proc. 2019 05; 94(5):811-819.
    View in: PubMed
    Score: 0.131
  23. Myocardial performance index in hypertensive disorders of pregnancy: The relationship between blood pressures and angiogenic factors. Hypertens Pregnancy. 2017 May; 36(2):161-167.
    View in: PubMed
    Score: 0.115
  24. Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period. Circulation. 2015 Nov 03; 132(18):1726-33.
    View in: PubMed
    Score: 0.104
  25. Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1a pathway. FASEB J. 2014 Oct; 28(10):4324-34.
    View in: PubMed
    Score: 0.096
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.